HMGB1 and Sepsis: Administration of anti-HMGB1 antibodies and inhibitors (for example, ethyl pyruvate, nicotine and chloroquine) protects mice against lethal experimental sepsis3, establishing HMGB1 as a potential therapeutic target for sepsis and other inflammatory diseases4.